AHK-Cu

Unregulated

Also known as: Copper Tripeptide AHK, Ala-His-Lys:Copper

Anti-Aging & Skin

Last reviewed: April 28, 2026

A newer copper-binding tripeptide related to GHK-Cu but with a different amino acid sequence (Ala-His-Lys vs Gly-His-Lys). Emerging research suggests it may have distinct and potentially complementary effects on hair growth and skin rejuvenation.

Mechanism of Action

Binds copper ions similarly to GHK-Cu but activates different signaling pathways. Appears to stimulate Wnt/β-catenin signaling in hair follicle dermal papilla cells, promoting hair growth through a mechanism distinct from GHK-Cu's wound healing pathway.

Common Uses

  • Hair growth stimulation
  • Skin rejuvenation
  • Anti-aging
  • Wound healing support

Known Risks

  • Very limited research compared to GHK-Cu
  • Most studies are in vitro
  • Potential copper toxicity at high doses
  • Not well-characterized safety profile

Regulatory Status

Unregulated

No FDA regulatory category. Available as a research chemical and in some cosmetic formulations. Not subject to the same regulatory scrutiny as GHK-Cu injectable.

Common Protocols

Protocol information is for educational reference only. Dosing varies significantly by individual, condition, and physician guidance. Always work with a licensed healthcare provider.

Topical (serum/solution)

Typical Dose

0.01–0.1% concentration

Frequency

Once or twice daily

Cycle Length

Ongoing

Primarily used topically for hair and skin. Less research than GHK-Cu. Often combined with GHK-Cu in formulations for complementary effects.

Related Compounds

Research References

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy. Data is compiled from published research and regulatory sources and may not reflect the most recent developments.